Jobs / United States / Novartis Pharmaceuticals Corporation
Director, US Market Access Early Pipeline
Novartis Pharmaceuticals Corporation · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles3 certified filings for “ED, Portfolio & Early Pipeline Strategy” (Marketing Managers) in NJ: $199k–$199k, median $199k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. The pay stated here ($194,600) is below what this employer usually pays sponsored hires for this role. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary #LI-Remote This position can be based remotely anywhere in the U.S. (there may be some restrictions based on legal entity). Please note that this role would not provide relocation as a result. The expectation of working hours and travel (domestic and/or international) will be defined by the hiring manager. This position will require 10% travel. Imagine influencing the future of medicine before it reaches patients. As Director, Market Access Early Pipeline, you will play a critical role in shaping how Novartis invests across its innovative pipeline, helping determine which assets advance and how they are developed to maximize patient access and commercial success. Partnering with leaders across Research & Development, Global Strategy, Clinical Development, and US Commercial teams, you will provide market access insights that guide key investment decisions, optimize evidence generation strategies, and ultimately help bring transformative therapies to patients who need them most. This is a unique opportunity to combine strategic thinking, market access expertise, and cross-functional leadership to make an impact on the future of healthcare. Job Description Key Responsibilities: • Providing US Market Access forecasting assumptions, including pricing (gross and net), anticipated payer coverage, and the implications of quality of coverage on physician demand and patient Rx fulfillment for assets and indications • Developing strategies to optimize payer coverage, patient affordability, and sales revenue for assets being considered across multiple indications and therapeutic areas • Conducting relevant payer market research, analyzing secondary data, and incorporating internal Novartis experience to inform assumptions and recommendations • Assessing clinical trial designs for potential market access risks and/or opportunities to optimize coverage and patient access (e.g., formulation, dosing, outcomes, potential data that would support positive coverage determinations, choice of comparator, potential cost-offset data) • Collaborating across multiple teams within the US and Global organizations to create disease area assessments for assets at proof of concept and ensuring that the organization understands what it would take to be commercially successful in different disease areas, including the key criteria needed to support a commercial case and decision to progress an asset into phase 2 Essential Requirements: • Education: Bachelor’s degree required; MBA, Health Policy or equivalent preferred • Minimum of 7 years of pharmaceutical experience in Market Access, Marketing, Managed Care Finance, Insights & Analytics or Business Development • Awareness and understanding of US healthcare dynamics and the drivers of pharmaceutical value • Strong interpersonal, communication, and influencing skills combined with an ability to successfully collaborate across a matrix organization • Ability to analyze complex business issues and trends and to connect commercial, financial, and clinical perspectives to develop enhanced value propositions Desirable Requirements: • Experience in Oncology therapeutic area Novartis Compensation Summary: The salary for this position is expected to range between $194,600 and $361,400 per year. The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors. Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards. US-based eligible employees will receive a comprehensive benefits packag